{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:44:17Z","timestamp":1779317057593,"version":"3.51.4"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Metastasis is the major cause of thyroid cancer morbidity and mortality. However, the mechanisms are still poorly understood. <\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed genome-wide transcriptome analysis comparing gene expression profile of metastatic thyroid cancer cells (Met) with primary tumor cells established from transgenic mouse models of papillary thyroid cancer (PTC), follicular thyroid cancer (FTC), poorly differentiated thyroid cancer (PDTC), and anaplastic thyroid cancer (ATC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Genes involved in tumor microenvironment (TME), inflammation, and immune escape were significantly overexpressed in Met cells. Notably, IL-6-mediated inflammatory and PD-L1 pathways were highly active in Met cells with increased secretion of pro-inflammatory and pro-metastatic cytokines such as CCL2, CCL11, IL5, IL6, and CXCL5. Furthermore, Met cells showed robust overexpression of Tbxas1, a thromboxane A synthase 1 gene that catalyzes the conversion of prostaglandin H2 to thromboxane A2 (TXA2), a potent inducer of platelet aggregation. Application of aspirin, a TXA2 inhibitor, significantly reduced lung metastases. Mertk, a member of the TAM (Tyro, Axl, Mertk) family of RTKs, was also overexpressed in Met cells, which led to increased MAPK activation, epithelial\u2013mesenchymal transition (EMT), and enrichment of cancer stem cells. Braf-mutant Met cells developed resistance to BRAFV600E inhibitor PLX4720, but remained sensitive to \u03b2-catenin inhibitor PKF118-310.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We have identified several overexpressed genes\/pathways in thyroid cancer metastasis, making them attractive therapeutic targets. Given the complexity of metastasis involving multiple pathways (PD-L1, Mertk, IL6, COX-1\/Tbxas1-TXA2), simultaneously targeting more than one of these pathways may be warranted to achieve better therapeutic effect for metastatic thyroid cancer.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1514264","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T05:17:02Z","timestamp":1739164622000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Genome-wide transcriptome analysis and drug target discovery reveal key genes and pathways in thyroid cancer metastasis"],"prefix":"10.3389","volume":"16","author":[{"given":"Minjing","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Qattan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monther","family":"Al-Alwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazem","family":"Ghebeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naif","family":"Binjumah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latifa","family":"Al-Haj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid S. A.","family":"Khabar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulmohsen","family":"Altaweel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falah","family":"Almohanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah M.","family":"Assiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelilah","family":"Aboussekhra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali S.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.v136.9","article-title":"Thyroid cancer mortality and incidence: a global overview","volume":"136","author":"La Vecchia","year":"2015","journal-title":"Int J Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974-2013","volume":"317","author":"Lim","year":"2017","journal-title":"Jama"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2016.110","article-title":"The changing incidence of thyroid cancer. Nature reviews Endocrinology","volume":"12","author":"Kitahara","year":"2016","journal-title":"Nat Rev Endo."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2503","article-title":"The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations","volume":"99","author":"Jung","year":"2014","journal-title":". J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9207-5","article-title":"Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging","volume":"14","author":"Lang","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1","article-title":"A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns","volume":"83","author":"Hundahl","year":"1998","journal-title":"Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0509","article-title":"Poorly differentiated carcinoma of the thyroid gland: current status and future prospects","volume":"29","author":"Ibrahimpasic","year":"2019","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/pin.v68.12","article-title":"The new 4th edition World Health Organization classification for thyroid tumors, Asian perspectives","volume":"68","author":"Kakudo","year":"2018","journal-title":"Pathol Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.142","article-title":"Molecular genetics and diagnosis of thyroid cancer","volume":"7","author":"Nikiforov","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1200\/JCO.2014.56.8253","article-title":"Association between BRAF V600E mutation and recurrence of papillary thyroid cancer","volume":"33","author":"Xing","year":"2015","journal-title":"J Clin oncology: Off J Am Soc Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12916-016-0559-9","article-title":"Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearer","volume":"14","author":"Xing","year":"2016","journal-title":"BMC Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3390\/cells10051082","article-title":"2021 the genomic landscape of thyroid cancer tumourigenesis and implications for immunotherapy","volume":"10","author":"Singh","year":"2021","journal-title":"Cells"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-01999-6","article-title":"Clinical outcomes and prognostic factors in patients with no less than three distant organ system metastases from differentiated thyroid carcinoma","volume":"66","author":"Zhang","year":"2019","journal-title":"Endocrine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0173","article-title":"Multi-organ distant metastases confer worse disease-specific survival in differentiated thyroid cancer","volume":"24","author":"Wang","year":"2014","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-017-0742-4","article-title":"Factors involved in cancer metastasis: a better understanding to \u201cseed and soil\u201d hypothesis","volume":"16","author":"Liu","year":"2017","journal-title":"Mol Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3390\/cancers13071625","article-title":"Site-specific metastasis and survival in papillary thyroid cancer: the importance of brain and multi-organ disease","volume":"13","author":"Toraih","year":"2021","journal-title":"Cancers"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz078","article-title":"Divergent metastatic patterns between subtypes of thyroid carcinoma results from the nationwide dutch pathology registry","volume":"105","author":"Hugen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/labinvest.2015.126","article-title":"Shi Y. IL-12 immunotherapy of Braf(V600E)-induced papillary thyroid cancer in a mouse model","volume":"96","author":"Parhar","year":"2016","journal-title":"Lab Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2015.90","article-title":"KRAS(G12D)-mediated oncogenic transformation of thyroid follicular cells requires long-term TSH stimulation and is regulated by SPRY1","volume":"95","author":"Zou","year":"2015","journal-title":"Lab Invest"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.253","article-title":"TSH overcomes Braf(V600E)-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer","volume":"35","author":"Zou","year":"2016","journal-title":"Oncogene"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-2066","article-title":"cyp24a1 attenuation limits progression of braf(V600E) -induced papillary thyroid cancer cells and sensitizes them to BRAF(V600E) inhibitor PLX4720","volume":"77","author":"Zou","year":"2017","journal-title":"Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1729299","DOI":"10.1080\/2162402X.2020.1729299","article-title":"PD-L1 is overexpressed on breast cancer stem cells through notch3\/mTOR axis","volume":"9","author":"Mansour","year":"2020","journal-title":"Oncoimmunology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1061803","article-title":"In vitro propagation and transcriptional profiling of human mammary stem\/progenitor cells","volume":"17","author":"Dontu","year":"2003","journal-title":"Genes Dev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","article-title":"Key chemokines direct migration of immune cells in solid tumors","volume":"29","author":"Kohli","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI145296","article-title":"Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment","volume":"131","author":"Su","year":"2021","journal-title":"J Clin Invest"},{"key":"B26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/ph14020130","article-title":"MERTK inhibition: potential as a treatment strategy in EGFR tyrosine kinase inhibitor-resistant non-small cell lung cancer","volume":"14","author":"Chen","year":"2021","journal-title":"Pharm (Basel Switzerland)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-21-0037","article-title":"[amp]]beta;-catenin attenuation inhibits tumor growth and promotes differentiation in a BRAF(V600E)-driven thyroid cancer animal model","volume":"20","author":"Zou","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"B28","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1242\/dev.110403","article-title":"The WNT-controlled transcriptional regulator LBH is required for mammary stem cell expansion and maintenance of the basal lineage","volume":"142","author":"Lindley","year":"2015","journal-title":"Dev (Cambridge England)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2029.428659","DOI":"10.1101\/2021.01.29.428659","article-title":"LBH is a cancer stem cell- and metastasis-promoting oncogene essential for WNT stem cell function in breast cancer","volume":"2001","author":"Garikapati","year":"2021","journal-title":"bioRxiv"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2017.118","article-title":"A high-throughput in vivo screening method in the mouse for identifying regulators of metastatic colonization","volume":"12","author":"Speak","year":"2017","journal-title":"Nat Protoc"},{"key":"B31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-1147","article-title":"Chemotherapy-induced metastasis: molecular mechanisms, clinical manifestations, therapeutic interventions","volume":"79","author":"Karagiannis","year":"2019","journal-title":"Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-10-0258","article-title":"Cisplatin treatment induces a transient increase in tumorigenic potential associated with high interleukin-6 expression in head and neck squamous cell carcinoma","volume":"9","author":"Poth","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S60114","article-title":"Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis","volume":"7","author":"Vyas","year":"2014","journal-title":"OncoTargets Ther"},{"key":"B35","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/path.2015.237.issue-2","article-title":"Specific chemotherapeutic agents induce metastatic behaviour through stromal- and tumour-derived cytokine and angiogenic factor signalling","volume":"237","author":"Liu","year":"2015","journal-title":"J Pathol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.3390\/ijms19113333","article-title":"Chemotherapy-exacerbated breast cancer metastasis: A paradox explainable by dysregulated adaptive-response","volume":"19","author":"Middleton","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"110490","DOI":"10.1016\/j.celrep.2022.110490","article-title":"On the origin of metastases: Induction of pro-metastatic states after impending cell death via ER stress, reprogramming, and a cytokine storm","volume":"38","author":"Conod","year":"2022","journal-title":"Cell Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/JCI169653","article-title":"Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics","volume":"133","author":"Lu","year":"2023","journal-title":"J Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/path.2018.246.issue-3","article-title":"Pulmonary metastatic colonisation and granulomas in NOX2-deficient mice","volume":"246","author":"van der Weyden","year":"2018","journal-title":"J Pathol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/path.2019.247.issue-2","article-title":"NOX2 in autoimmunity, tumor growth and metastasis","volume":"247","author":"Martner","year":"2019","journal-title":"J Pathol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI99317","article-title":"Contribution of NK cells to immunotherapy mediated by PD-1\/PD-L1 blockade","volume":"128","author":"Hsu","year":"2018","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1509819","article-title":"PD-L1 blockade enhances anti-tumor efficacy of NK cells","volume":"7","author":"Oyer","year":"2018","journal-title":"Oncoimmunology"},{"key":"B43","article-title":"PD-1\/PD-L1 pathway: current researches in cancer","volume":"10","author":"Han","year":"2020","journal-title":"Am J Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI126022","article-title":"IL-6\/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion","volume":"129","author":"Chan","year":"2019","journal-title":"J Clin Invest"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40425-018-0316-z","article-title":"Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations","volume":"6","author":"Gong","year":"2018","journal-title":"J immunotherapy Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2610","article-title":"T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10","volume":"14","author":"Bandala-Sanchez","year":"2013","journal-title":"Nat Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1722056115","article-title":"CD52 glycan binds the proinflammatory B box of HMGB1 to engage the Siglec-10 receptor and suppress human T cell function","volume":"115","author":"Bandala-Sanchez","year":"2018","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.035899","article-title":"Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone","volume":"284","author":"Lu","year":"2009","journal-title":"J Biol Chem"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.9.6384","article-title":"CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process","volume":"181","author":"Wu","year":"2008","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.3390\/cells11223698","article-title":"The role of IL-6 in cancer cell invasiveness and metastasis-overview and therapeutic opportunities","volume":"11","author":"Ra\u0161kov\u00e1","year":"2022","journal-title":"Cells"},{"key":"B53","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.1038\/ncomms5715","article-title":"Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis","volume":"5","author":"Lee","year":"2014","journal-title":"Nat Commun"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1172\/JCI121985","article-title":"Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1\/thromboxane A2","volume":"129","author":"Lucotti","year":"2019","journal-title":"J Clin Invest"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet (London England)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.3390\/cancers14102498","article-title":"Platelets increase the expression of PD-L1 in ovarian cancer","volume":"14","author":"Cho","year":"2022","journal-title":"Cancers"},{"key":"B58","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.1038\/s41467-021-27303-7","article-title":"Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer","volume":"12","author":"Hinterleitner","year":"2021","journal-title":"Nat Commun"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-19-1106","article-title":"Repurposing of a thromboxane receptor inhibitor based on a novel role in metastasis identified by phenome-wide association study","volume":"19","author":"Werfel","year":"2020","journal-title":"Mol Cancer Ther"},{"key":"B60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/bs.ircmb.2022.04.004","article-title":"Mertk: An emerging target in cancer biology and immuno-oncology","volume":"368","author":"Lahey","year":"2022","journal-title":"Int Rev Cell Mol Biol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2024941","DOI":"10.1080\/2162402X.2021.2024941","article-title":"MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression","volume":"11","author":"Lin","year":"2022","journal-title":"Oncoimmunology"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-16-0350","article-title":"Phosphatidylserine sensing by TAM receptors regulates AKT-dependent chemoresistance and PD-L1 expression","volume":"15","author":"Kasikara","year":"2017","journal-title":"Mol Cancer research: MCR"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nature12998","article-title":"The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells","volume":"507","author":"Paolino","year":"2014","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4297","article-title":"Unleashing NK cell anti-metastatic activity","volume":"13","author":"Flemming","year":"2014","journal-title":"Nat Rev Drug Discovery"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.598477","article-title":"A potent and selective dual inhibitor of AXL and MERTK possesses both immunomodulatory and tumor-targeted activity","volume":"10","author":"Rios-Doria","year":"2020","journal-title":"Front Oncol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1514264\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T05:17:05Z","timestamp":1739164625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1514264\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":65,"alternative-id":["10.3389\/fendo.2025.1514264"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1514264","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"article-number":"1514264"}}